Latest Liquidity News

Immutep Limited has initiated its pivotal Phase III trial for eftilagimod alfa in first-line non-small cell lung cancer, supported by compelling survival outcomes from ongoing studies and a robust cash position expected to fund operations through 2026.

Axiom Properties Limited reported a $518,000 increase in cash reserves for the December quarter, reaching $1.86 million, while extending key debt facilities to support its Mt Barker development and the rapidly expanding ListSure business.

Brookside Energy Ltd delivered a standout quarter in Q4 2024, posting record production growth and a 667% jump in operating cash flow, while completing a major development project ahead of schedule and under budget.

Vitrafy Life Sciences reports strong Q2 FY2025 progress, marked by a successful $35 million IPO, promising validation results in animal and human health, and strategic expansion into North America.

New Frontier Minerals Limited has reshaped its portfolio by divesting the Cangai Copper Mine and acquiring the highly prospective Harts Range Project, positioning itself at the forefront of critical mineral exploration.

Donaco International posted modest revenue and EBITDA gains in Q2 FY2025, alongside a stronger cash position, while navigating regulatory uncertainties in Southeast Asia.

Omni Bridgeway Limited reports strong investment proceeds and new commitments in the first half of FY25, alongside significant cost savings and the imminent financial close of Fund 9 with Ares Management.

Alma Metals reports strong drilling results at its Briggs Copper Project, revealing higher-grade copper zones near surface and a promising new mineralisation discovery at the Southern Porphyry Target. The company advances its resource update and mining studies with a solid cash position.

Almonty Industries has locked in final commitments for an AUD 18.45 million equity placement from existing shareholders, aiming to strengthen its financial position and cover offer costs. The placement includes warrants and options, with closing pending regulatory approval.

Medical Developments International has posted a robust improvement in operating cash flow and revenue for Q2 FY25, driven by higher demand and pricing for its flagship product Penthrox across Australia and Europe.

MTM Critical Metals reported major progress in its Flash Joule Heating technology and secured $15.5 million in capital raises, positioning itself for commercialisation and strategic growth in critical metals recovery.

SRJ Technologies reported a remarkable 178% increase in Q4 FY24 cash receipts, driven by strong contract activity and strategic partnerships, including a key Middle East market entry. Despite some project delays, the company remains confident in its growth trajectory for FY25.